Matthew Kubit
Overview
Explore the profile of Matthew Kubit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almeda A, Grimes S, Lee H, Greer S, Shin G, McNamara M, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1693-1700.
PMID: 35771165
Background: Gastric cancer is a leading cause of cancer morbidity and mortality. Developing information systems which integrate clinical and genomic data may accelerate discoveries to improve cancer prevention, detection, and...
2.
Zhao L, Grimes S, Greer S, Kubit M, Lee H, Nadauld L, et al.
NAR Cancer
. 2022 Jan;
3(4):zcab049.
PMID: 34988460
Dysbioisis is an imbalance of an organ's microbiome and plays a role in colorectal cancer pathogenesis. Characterizing the bacteria in the microenvironment of a cancer through genome sequencing has advantages...
3.
Andor N, Lau B, Catalanotti C, Sathe A, Kubit M, Chen J, et al.
NAR Genom Bioinform
. 2020 Mar;
2(2):lqaa016.
PMID: 32215369
Cancer cell lines are not homogeneous nor are they static in their genetic state and biological properties. Genetic, transcriptional and phenotypic diversity within cell lines contributes to the lack of...
4.
Xia L, Van Hummelen P, Kubit M, Lee H, Bell J, Grimes S, et al.
Sci Rep
. 2020 Mar;
10(1):5009.
PMID: 32193467
DNA copy number aberrations (CNA) are frequently observed in colorectal cancers (CRC). There is an urgent need for CNA-based biomarkers in clinics,. n For Stage III CRC, if combined with...
5.
Taskova M, Uhd J, Miotke L, Kubit M, Bell J, Ji H, et al.
Anal Chem
. 2017 Apr;
89(8):4363-4366.
PMID: 28382823
New approaches for genomic DNA/RNA detection are in high demand in order to provide controls for existing enzymatic technologies and to create alternatives for emerging applications. In particular, there is...